Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.
Press releases published on May 1, 2025

National Bar Association President Issues Statement Condemning Trump Administration’s Attempt to Erase Black History
Wiley S. Adams denounces removal of key African American artifacts from the Smithsonian as a direct attack on truth and justice WASHINGTON, DC, UNITED STATES, May 1, 2025 /EINPresswire.com/ -- Wiley S. Adams, President of the National Bar Association, …

Report Highlights Profitable Pathways Created by Heifer International and Hello Tractor for Africa’s Smallholder Farmers
Blended Finance Model: Report Highlights Profitable Pathways Created by Heifer International and Hello Tractor for Africa’s Smallholder Farmers NAIROBI, KENYA, May 1, 2025 /EINPresswire.com/ -- A new report from Aceli Africa and Dalberg confirms the …

President Julius Maada Bio Launches 'Freetown Roadmap' to Advance UN Security Council Reform
Sierra Leone hosts C-10 Retreat as President Bio calls for Africa’s rightful place in global peace and security governance. FREETOWN, WESTERN AREA URBAN DISTRICT, SIERRA LEONE, May 1, 2025 /EINPresswire.com/ -- Sierra Leone’s President, Dr. Julius Maada …

MacroGenics to Participate in Upcoming Investor Conference
ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update
Company reports $74.1 million in Q1 total revenue, reflecting 61% growth year-over-year IBSRELA net product sales revenue of $44.4 million; XPHOZAH net product sales revenue of $23.4 million Company ends Q1 with $214.0 million in cash, cash equivalents …

Calibre Securityholders Approve Business Combination with Equinox Gold
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the “Company” or “Calibre”) is pleased to announce that holders of Calibre common shares (the “Shareholders”) and holders of options issued under …

Mining Will Secure BC’s Economic Future
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- Twenty-seven mining projects, representing $90 billion in economic activity have the potential to deliver major benefits for BC and Canada at a time of global instability, a slowing provincial …

Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced today that new data supporting its AAV …

SPR Expands Access to the SPRINT® PNS System for Veterans with New Distribution Agreement with Veteran’s Health Medical Supply
- National clinical review and contract offers an easier path to care for millions of Veterans - CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- SPR announced today that the SPRINT PNS System is now available on the Department of Veteran’s Affairs (VA) …

Rio Silver completes Definitive Agreement for the sale of Ninobamba, announces planned restructuring
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF), announces that it has completed a definitive agreement (the “Option Agreement”) with Magma Silver Corp. (TSX.V: MGMA) …

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025
BASKING RIDGE, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious …

Altimmune to Present at Upcoming EASL International Liver Congress™ 2025
GAITHERSBURG, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced that the …

Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
– Reported positive topline results from the Phase 3 VERITAC-2 trial that support global regulatory filings – – Presented first-in-human data for the Company’s first neuroscience program with ARV-102 showing blood-brain barrier penetration and central and …

Eccogene Appoints Dr. Jai Patel as Chief Medical Officer
BOSTON and SHANGHAI, May 01, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced the appointment …

BioCryst Appoints Steve Frank to Board of Directors
RESEARCH TRIANGLE PARK, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed healthcare investment banking leader Steve Frank to its board of directors. Mr. Frank serves as …

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report first quarter 2025 financial results on May 12, 2025, before the open of the U.S. financial markets. The company does not intend to hold a …

Ligand to Participate in May Investor Conferences
JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: H.C. Wainwright Royalty Company Conference ( …

Enara Bio Strengthens Senior Leadership with Key Executive and Board Appointments Alongside Acceleration of Multiple T-Cell Engager Programs
Stacey Davis appointed as Chief Business Officer and Chief Financial Officer Clive Wood, Ph.D. joins Enara Board as Non-executive Director Oxford, United Kingdom – May 01, 2025. Enara Bio, a biopharmaceutical company pioneering the development of …